Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”
Clinical and Molecular Hepatology · 20.08.2026
DOI: 10.3350/cmh.2026.0761 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 20.08.2026. Verfasst von Lijun Ge und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China, 661199.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacy, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China, 661199.
- Lijun Ge and Yu Xu equally contributed to the study.
- Department of Pharmacy, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China, 661199. ly2120303@163.com.
Zitieren
APA
Ge, L., Xu, Y., & Yan, J. (2026). Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0761
Vancouver
Ge L, Xu Y, Yan J. Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0761
BibTeX
@article{Ge2026,
author = {Ge, Lijun and Xu, Yu and Yan, Jinfang},
title = {Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0761}
}
EUVIMED